Patent · US Active

Cyclic adenosine monophosphates for reducing the formation of adhesions

US8927521B2 · kind B2 · utility

12Cited by
3References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 5, 2009
Grant dateJan 6, 2015
Priority date
Expiry dateNov 20, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods of reducing adhesion formation in a subject, for example, post-surgical abdominal and pelvic adhesions. The methods include the step of administering to the subject in need thereof a compound chosen from 2′,3′-cyclic adenosine monophosphate, analogs thereof, and pharmaceutically acceptable salts thereof, able to reduce the formation of adhesions in a subject as compared to adenosine monophosphate, in an amount effective to reduce adhesions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.